Stocks and Investing Stocks and Investing
Tue, November 5, 2019
Mon, November 4, 2019
Fri, November 1, 2019
Thu, October 31, 2019
Wed, October 30, 2019

Aaron Gal Upgraded (BIIB) to Buy on, Oct 30th, 2019


Published on 2024-10-26 17:35:37 - WOPRAI
  Print publication without navigation


Aaron Gal of Bernstein, Upgraded "Biogen Inc." (BIIB) to Buy on, Oct 30th, 2019.

Aaron has made no other calls on BIIB in the last 4 months.



There are 9 other peers that have a rating on BIIB. Out of the 9 peers that are also analyzing BIIB, 3 agree with Aaron's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $297 on, Wednesday, October 23rd, 2019
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $305 on, Wednesday, October 23rd, 2019


These are the ratings of the 6 analyists that currently disagree with Aaron


  • Adnan Butt of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, October 23rd, 2019
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $335 on, Wednesday, October 23rd, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Sell with Increased Target to $260 on, Wednesday, October 23rd, 2019
  • Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $350 on, Wednesday, October 23rd, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Increased Target to $262 on, Wednesday, October 23rd, 2019
  • Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $325 on, Wednesday, October 23rd, 2019